The DOI matches its Crossref record; 249 of the 262 references it cites were found in a registry or an index.
Cannabinoid receptors and pain
Abstract
Mammalian tissues contain at least two types of cannabinoid receptor, CB(1) and CB(2), both coupled to G proteins. CB(1) receptors are expressed mainly by neurones of the central and peripheral nervous system whereas CB(2) receptors occur centrally and peripherally in certain non-neuronal tissues, particularly in immune cells. The existence of endogenous ligands for cannabinoid receptors has also been demonstrated. The discovery of this 'endocannabinoid system' has prompted the development of a range of novel cannabinoid receptor agonists and antagonists, including several that show marked selectivity for CB(1) or CB(2) receptors. It has also been paralleled by a renewed interest in cannabinoid-induced antinociception. This review summarizes current knowledge about the ability of cannabinoids to produce antinociception in animal models of acute pain as well as about the ability of these drugs to suppress signs of tonic pain induced in animals by nerve damage or by the injection of an inflammatory agent. Particular attention is paid to the types of pain against which cannabinoids may be effective, the distribution pattern of cannabinoid receptors in central and peripheral pain pathways and the part that these receptors play in cannabinoid-induced antinociception. The possibility that antinociception can be mediated by cannabinoid receptors other than CB(1) and CB(2) receptors, for example CB(2)-like receptors, is also discussed as is the evidence firstly that one endogenous cannabinoid, anandamide, produces antinociception through mechanisms that differ from those of other types of cannabinoid, for example by acting on vanilloid receptors, and secondly that the endocannabinoid system has physiological and/or pathophysiological roles in the modulation of pain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cannabinoids produce analgesia either in animal models of pain (both acute pain and tonic pain) or in clinical painful conditions (for reviews see: 161,221), and endogenous cannabinoids are tonically released to participate in the control of basal nociceptive threshold (137).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [161]
In the citing paper
“Cannabinoid receptor 1 (CB1) is predominantly distributed in the nerve cells of both the CNS and PNS and regulates both the sensory and affective components of pain, while cannabinoid receptor 2 (CB2) is expressed mainly on immune cells, including central glial cells and peripheral immune cells (152).”
From Nociplastic pain: the prominent role of non-neuronal cells in central and peripheral sensitization (2026) · cites this paper as [152]
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Self-citationHerkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Self-citationKatona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Research works printed but not linked: 9
- Bhattacharya, 1989, Role of prostaglandins in some neuropharmacological actions of delta-9-tetrahydrocannabinol (THC) in the rat, Asia Pacific J. Pharmacol., 4, 179
- Breivogel, C.S., Walker, J.M., Huang, S., Childers, S.R., 1999. Cannabinoid signalling in cultured rat cerebellar granule cells. International Cannabinoid Research Society 1999, Symposium on the Cannabinoids, Burlington, Vermont, p. 19.
- Cowan, A., Pars, H.G., Razdan, R.K., Harris, L.S., Dewey, W.L., Essigmann, E.M., 1985. Antinociceptive activity of menabitan. In: Harvey, D.J. (Ed.), Marijuana '84, IRL Press, Oxford, pp. 693–699.
- Finnegan-Ling, D., Musty, R.E., 1994. Marinol and phantom limb pain: a case study, Proc. Int. Cannabinoid. Res. Soc., p. 53.
- Kathmann, M., Nakazi, M., Bauer, U., Schlicker, E., 1999b. WIN 55212-2 inhibits serotonin release in the mouse brain cortex via presynaptic cannabinoid CB1 receptors. International Cannabinoid Research Society 1999, Symposium on the Cannabinoids, Burlington, Vermont, p. 51.
- Kaymakcalan, 1972, Some pharmacologic properties of synthetic Δ9-tetrahydrocannabinol (THC), Acta Med. Turcica, Suppl. 1, 5
- Kearn, C.S., Hillard, C.J., 1999. A model for the study of cannabinoid actions in microglia. International Cannabinoid Research Society 1999, Symposium on the Cannabinoids, Burlington, Vermont, p. 44.
- Martin, B.R., 1985a. Characterization of the antinociceptive activity of intravenously administered delta-9-tetrahydrocannabinol in mice. In: Harvey, D.J. (Ed.), Marihuana ‘84 IRL Press, Oxford, pp. 685–692.
- Ross, 1999, Evidence for cannabinoid receptor-mediated inhibition of voltage-activated Ca2+ currents in neonatal rat cultured DRG neurones, Br. J. Pharmacol., 128, 13P
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationThe endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
“We next analysed whether the differences in memory extinction between the two genotypes could be attributed to alterations in sensory-motor abilities of CB1 -/- mice, as cannabinoids are known to influence pain perception, emotionality and locomotio”
BackgroundRole of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Metadata
- Authors
- Pertwee, R. G.
- Affiliations
- University of Aberdeen (GB)
- Corresponding author
- Pertwee, Roger G.
- ORCID
- Pertwee, Roger G.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 63
- Issue
- 5
- Pages
- 569-611
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W1982186440
- Cited by
- 741
- References
- 262
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 21 · 2023: 19 · 2022: 19 · 2021: 18 · 2020: 28 · 2019: 24 · 2018: 21 · 2017: 25 · 2016: 14 · 2015: 21 · 2014: 33 · 2013: 30 · 2012: 36
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- cannabinoid receptors, CB1 receptor, CB2 receptor, endocannabinoid system, antinociception, pain, acute pain, neuropathic pain, inflammatory pain, anandamide, vanilloid receptor, cannabinoid receptor agonists, cannabinoid receptor antagonists, G protein-coupled receptors, pain modulation
- MeSH terms
- Acute Disease, Analgesics, Animals, Haplorhini, Brain, Cannabinoids, Chronic Disease, Disease Models, Animal, Humans, Ligands, Pain, Pain Measurement, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Mice, Rats, Cannabinoid Receptor Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cannabinoid receptors and pain. https://app.cochat.ai/papers/10.1016/s0301-0082(00)00031-9
- The paper
- Pertwee, R. G. (2001). Cannabinoid receptors and pain. Progress in Neurobiology. https://doi.org/10.1016/s0301-0082(00)00031-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.